[HTML][HTML] Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica–A systematic review and meta-analysis

AW Nielsen, LL Frølund, C Våben, AR Bonde… - Seminars in Arthritis and …, 2022 - Elsevier
Introduction Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) can be concurrent
diseases. We aimed to estimate the point-prevalence of concurrent GCA and PMR …

Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review

I Coskun Benlidayi - Clinical Rheumatology, 2024 - Springer
Polymyalgia rheumatica is one of the most common inflammatory rheumatic conditions in
older adults. The disease is characterized by pain and stiffness in the shoulder and pelvic …

JAK inhibitors and black box warnings: what is the future for JAK inhibitors?

K Tokareva, P Reid, V Yang, D Liew… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Janus kinase inhibitors (JAKi) have dramatically improved the
treatment of various autoimmune and myeloproliferative disorders. Recently, concern has …

Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: differences in pathogenesis

J Wu, F Yang, X Ma, J Lin, W Chen - Frontiers in Medicine, 2023 - frontiersin.org
Rheumatoid arthritis is a chronic autoimmune disease that mainly affects the facet joints.
Elderly-onset rheumatoid arthritis appears to exhibit symptoms similar to those of …

Rheumatic immune-related adverse events due to immune checkpoint inhibitors—a 2023 update

QM Dang, R Watanabe, M Shiomi, K Fukumoto… - International Journal of …, 2023 - mdpi.com
With the aging of the population, malignancies are becoming common complications in
patients with rheumatoid arthritis (RA), particularly in elderly patients. Such malignancies …

Effects of whole-body cryostimulation on pain management and disease activity in active rheumatic polymyalgia: a case-report

F Verme, A Scarpa, G Varallo, P Piterà, P Capodaglio… - Biomedicines, 2023 - mdpi.com
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease among
people over 50 and occurs with symptoms such as musculoskeletal pain and stiffness in the …

[PDF][PDF] Polymyalgia rheumatica: When should we suspect an underlying large vessel vasculitis

MA González-Gay, EF Vicente-Rabaneda… - Ann. Rheum …, 2023 - clinexprheumatol.org
CT demonstrated the presence of LV vasculitis in 42 of the 84 patients with PMR. However,
Camellino et al. did not find a significant correlation between clinical findings and FDG …

Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland

J Paltta, S Suuronen, L Pirilä… - Scandinavian Journal of …, 2023 - Taylor & Francis
Objectives Diagnosing polymyalgia rheumatica (PMR) can be difficult as many conditions
present with similar symptoms and findings. This study aimed to analyse how often the …

Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

E Hysa, M Bond, L Ehlers, D Camellino, L Falzon… - …, 2024 - academic.oup.com
Objectives To inform an international task force about current evidence on Treat to Target
(T2T) strategies in PMR and GCA. Methods A systematic literature research (SLR) was …

Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic …

E Hysa, A Casabella, E Gotelli, R Campitiello… - Autoimmunity …, 2024 - Elsevier
Introduction An altered immune tolerance disturbed by immune checkpoint inhibitors (ICIs)
may contribute to new-onset polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) …